The prosurvival effects of the MEK/ERK pathway in tumor cells have been shown to pass through the upregulation or stimulation of different antiapoptotic factors such as Bcl-2, Bim, or Bad (for review see [161]). Here, MAP2K7 is linked to neoplasm.